Inclusion Criteria:  Men and women over 18 years of age. Systolic blood pressure between 130- 159 mm Hg. Not under pharmacological treatment or have completed pharmacological treatment at least one month before the start of the study with anti-hypertensive and/or with lipid-lowering drugs. 2. Sign the informed consent.  Exclusion Criteria:  BMI ≥ 35 kg/m^2. Have a clinical history of chronic kidney disease, cardiovascular disease and/or cancer. Be a smoker or ex-smoker in the last 6 months before inclusion in the study. Present diabetes. Take supplements with polyphenol components or aimed to lipid or blood pressure control during their participation in the study. Take 2 or more Standard Beverage Units daily or 17 weekly for women, or take 4 or more Standard Beverage Units daily or 28 weekly for men. Present some chronic gastrointestinal disease. Present food intolerances and/or allergies related to the products of the study, such as hypersensitivity to maltodextrin and/or sulfites. Being pregnant or intending to become pregnant. Be in breastfeeding period. Participate in or have participated in a clinical trial with drugs or nutritional intervention study in the last 30 days prior to inclusion in the study. Being unable to follow the study guidelines.